ARCT 20.55 (-2.19%)
US03969T1097BiotechnologyBiotechnology

Arcturus Therapeutics Holdings (ARCT) Stock Highlights

20.55 | -2.19%
2024-09-19 04:14:41
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the segment of research and development of medical applications for nucleic acid-focused technology. The product pipeline of the company includes LUNAR-OTC, LUNAR-CF, and LUNAR-COV19.

Statistics

Range Today
20.05 21.55
Volume Today 429.1K
Range 1 Year
17.52 45
Volume 1 Year 117.74M
Range 3 Year
11.7 54.7
Volume 3 Year 382.47M
Range 10 Year
4.11 150.71
Volume 10 Year 818.92M

Highlights

Market Capitalization 561.13M (small)
Floating Shares 24.74M
Current Price 20.55
Price To Earnings -7.52
Price To Revenue 2.02
Price To Book 2.17
Earnings Per Share -2.69
Payout Ratio 0%

Performance

Latest -2.19%
1 Month -0.39%
3 Months -26.97%
6 Months -43.04%
1 Year -28.55%
3 Years -60.48%
5 Years +87.33%
10 Years -83.91%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.